Skip to search formSkip to main contentSkip to account menu

Sclerostin Measurement

Known as: SOST, Sclerostin 
The determination of the amount of sclerostin present in a sample.
National Institutes of Health

Related topics

Related topics

5 relations
CDISC SDTM Laboratory Test Terminology by CodeCDISC SDTM Laboratory Test Terminology by NameClinical Data Interchange Standards Consortium TerminologySOST gene

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Application of anti-Sclerostin therapy in non-osteoporosis disease models.
2017
2017
Serum Sclerostin and Muscle Strength in Alcoholics
Background: Chronic alcoholic myopathy is a common complication of alcoholism, leading to muscle atrophy and reduced muscle… 
2016
2016
Value of Serum Sclerostin in Osteopenia and Osteoporosis Associated with Liver Cirrhosis and Post Liver Transplantation
Background: Osteodystrophy is one of the signs of liver cirrhosis. In general, maintenance of bone over time requires balance… 
2016
2016
Preliminary Findings on the Role of Sclerostin in the Osseointegration Process Around Titanium Implants.
PURPOSE Studies have recognized the importance of Wnt/β-catenin signals in osteoblastogenesis. Sclerostin is a glycoprotein… 
2015
2015
Circulating sclerostin and estradiol levels are associated with inadequate response to bisphosphonates in postmenopausal women with osteoporosis.
2014
2014
Update on romosozumab: a humanized monoclonal antibody to sclerostin
Introduction: Disorders with inactivating mutations of the SOST gene result in reduced or absent expression of sclerostin and are… 
2014
2014
Osteoblasts as leukemia-initiating cells.
Commentary on: Kode A, Manavalan JS, Mosialou I, Bhagat G, Rathinam CV, Luo N, Khiabanian H, Lee A, Murty VV, Friedman R, Brum A… 
2011
2011
Inhibition of Sclerostin by Monoclonal Antibody Enhances Bone Healing in Rat Osteotomy Model
Sclerostin is a negative regulator of bone formation and treatment with a sclerostin monoclonal antibody (Scl-Ab) results in… 
2010
2010
High Circulating Levels of Sclerostin Correlate with Bone Mineral Density In Patients with Thalassemia and Osteoporosis: The Role of the Wnt Signaling In the Pathogenesis of Bone Loss In Thalassemia
Abstract 1010 Osteoporosis represents an important cause of morbidity in adult patients with thalassemia. Osteoclast activity is… 
2008
2008
OPG and RANKL mRNA and protein expressions in the primary and secondary metaphyseal trabecular bone of PTH-treated rats are independent of that of SOST
Sclerostin, encoded by the SOST gene, is a recently identified protein which seems to affect bone remodeling by inhibiting bone… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)